Transposon Therapeutics
Transposon Therapeutics is a startup headquartered in San Diego, United States, founded in 2019. It has raised at least $4.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Transposon Therapeutics has raised at least $4.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Transposon Therapeutics sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in San Diego
- Acurion
- Address Insite
- Aervivo
- Algorithmic Objective
- Alida Biosciences
- AmbyTech
- Avenzo Therapeutics
- Candid Therapeutics
- Capstan Therapeutics
- CARI Health
- ClickUp
Related
- Innovation profile of San Diego
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Transposon Therapeutics do?
Transposon Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Transposon Therapeutics raised?
At least $4.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Transposon Therapeutics based?
Transposon Therapeutics is headquartered in San Diego, United States.
When was Transposon Therapeutics founded?
Transposon Therapeutics was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.